Kezar Life Sciences

📍 South San Francisco, United States🗓 Founded 2015👥 85 employees💰 Last funded Dec 2019
Biotechnology Research🌐 kezarlifesciences.com
Website LinkedIn
We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be applied across a vast array of indications to create victories for patients most in need.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Italy
1
United States
1
Frequently asked questions
Who invested in Kezar Life Sciences?
Kezar Life Sciences has 2 investors on record on gritt.io, 2 mid-stage.
When did Kezar Life Sciences last raise funding?
The most recent investment in Kezar Life Sciences recorded on gritt.io was in December 2019.
When was Kezar Life Sciences founded?
Kezar Life Sciences was founded in 2015.
What industry is Kezar Life Sciences in?
Kezar Life Sciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Kezar Life Sciences based?
Kezar Life Sciences is headquartered in South San Francisco, United States.